Dataset Information


Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry.

ABSTRACT: Childhood high-risk neuroblastomas with MYCN gene amplification are difficult to treat effectively1. This has focused attention on tumor-specific gene dependencies that underlie tumorigenesis and thus provide valuable targets for the development of novel therapeutics. Using unbiased genome-scale CRISPR-Cas9 approaches to detect genes involved in tumor cell growth and survival2-6, we identified 147 candidate gene dependencies selective for MYCN-amplified neuroblastoma cell lines, compared to over 300 other human cancer cell lines. We then used genome-wide chromatin-immunoprecipitation coupled to high-throughput sequencing analysis to demonstrate that a small number of essential transcription factors-MYCN, HAND2, ISL1, PHOX2B, GATA3, and TBX2-are members of the transcriptional core regulatory circuitry (CRC) that maintains cell state in MYCN-amplified neuroblastoma. To disable the CRC, we tested a combination of BRD4 and CDK7 inhibitors, which act synergistically, in vitro and in vivo, with rapid downregulation of CRC transcription factor gene expression. This study defines a set of critical dependency genes in MYCN-amplified neuroblastoma that are essential for cell state and survival in this tumor.


PROVIDER: S-EPMC6386470 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6901540 | BioStudies
2018-01-01 | S-EPMC6242972 | BioStudies
2018-05-22 | GSE94822 | GEO
2018-05-22 | GSE94823 | GEO
2018-05-22 | GSE108914 | GEO
1000-01-01 | S-EPMC5870584 | BioStudies
2019-01-01 | S-EPMC6451017 | BioStudies
1000-01-01 | S-EPMC4520635 | BioStudies
2020-01-01 | S-EPMC7540996 | BioStudies
2021-10-25 | GSE155000 | GEO